Geode Capital Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.76M | Buy |
676,431
+668,000
| +7,923% | +$6.67M | ﹤0.01% | 2577 |
|
|
2025
Q1 | $741K | Buy |
8,431
+12
| +0.1% | +$1.05K | ﹤0.01% | 3407 |
|
|
2024
Q4 | $781K | Buy |
8,419
+79
| +0.9% | +$7.33K | ﹤0.01% | 3450 |
|
|
2024
Q3 | $610K | Sell |
8,340
-722
| -8% | -$52.8K | ﹤0.01% | 3531 |
|
|
2024
Q2 | $527K | Buy |
9,062
+1,012
| +13% | +$58.8K | ﹤0.01% | 3555 |
|
|
2024
Q1 | $8.33M | Buy |
8,050
+139
| +2% | +$144K | ﹤0.01% | 2434 |
|
|
2023
Q4 | $6.27M | Buy |
7,911
+774
| +11% | +$613K | ﹤0.01% | 2588 |
|
|
2023
Q3 | $3.39M | Buy |
7,137
+1,335
| +23% | +$634K | ﹤0.01% | 2838 |
|
|
2023
Q2 | $3.48M | Buy |
5,802
+445
| +8% | +$267K | ﹤0.01% | 2885 |
|
|
2023
Q1 | $3.78M | Buy |
5,357
+254
| +5% | +$179K | ﹤0.01% | 2757 |
|
|
2022
Q4 | $5.23M | Buy |
5,103
+257
| +5% | +$263K | ﹤0.01% | 2640 |
|
|
2022
Q3 | $2.81M | Buy |
4,846
+99
| +2% | +$57.4K | ﹤0.01% | 2963 |
|
|
2022
Q2 | $2.6M | Sell |
4,747
-830
| -15% | -$454K | ﹤0.01% | 3021 |
|
|
2022
Q1 | $3.58M | Buy |
5,577
+1,070
| +24% | +$686K | ﹤0.01% | 2970 |
|
|
2021
Q4 | $1.86M | Buy |
4,507
+1,238
| +38% | +$511K | ﹤0.01% | 3398 |
|
|
2021
Q3 | $2.4M | Buy |
+3,269
| New | +$2.4M | ﹤0.01% | 3269 |
|